COM:AVIDITYBIOSCIENCES

Avidity Biosciences

Stock

Last Close

47.51

08/11 21:00

Market Cap

4.07B

Beta: -

Volume Today

1.08M

Avg: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-11.22M -	-24.73M 120.52%	-44.35M 79.33%	-118.01M 166.06%	-174.00M 47.44%	-212.22M 21.97%
depreciation and amortization	383K -	348K 9.14%	373K 7.18%	639K 71.31%	1.39M 117.06%	2.10M 51.48%
deferred income tax			84K -			-1.77M -
stock based compensation	60K -	406K 576.67%	4.31M 961.58%	17.06M 295.73%	27.14M 59.12%	38.22M 40.84%
change in working capital	671K -	19.12M 2,749.93%	2.33M 87.81%	5.34M 128.90%	9.82M 83.89%	61.13M 522.75%
accounts receivables
inventory
accounts payables		451K -	5.75M 1,174.72%	6.04M 5.11%	18.32M 203.08%	1.77M 90.34%
other working capital	671K -	18.67M 2,682.71%	-3.42M 118.30%	-705K 79.37%	-8.50M 1,105.53%	59.36M 798.44%
other non cash items	447K -	7.35M 1,543.62%	139K 98.11%	163K 17.27%	-615K 477.30%	-6.53M 961.30%
net cash provided by operating activities	-9.65M -	2.49M 125.79%	-37.12M 1,590.64%	-94.81M 155.44%	-136.27M 43.72%	-119.06M 12.63%
investments in property plant and equipment	-49K -	-235K 379.59%	-1.09M 364.68%	-3.74M 242.49%	-2.82M 24.52%	-4.23M 49.77%
acquisitions net				82.52M -	187.13M 126.78%
purchases of investments			-6.69M -	-85.36M 1,175.32%	-355.84M 316.88%	-461.00M 29.55%
sales maturities of investments				6.58M -	168.71M 2,463.91%	335.16M 98.67%
other investing activites				-82.52M -	-187.13M 126.78%
net cash used for investing activites	-49K -	-235K 379.59%	-7.79M 3,212.77%	-82.52M 959.95%	-189.96M 130.20%	-130.07M 31.53%
debt repayment		-2.80M -	-4.68M 67.25%
common stock issued		65K -	298.08M 458,484.62%	185.94M 37.62%	344.78M 85.43%	93.86M 72.78%
common stock repurchased			444K -
dividends paid		-106K -	-444K 318.87%
other financing activites		92.07M -	-21.36M 123.20%	-9.62M 54.95%	1.39M 114.47%
net cash used provided by financing activities	5.14M -	89.23M 1,634.70%	272.04M 204.86%	176.32M 35.19%	346.17M 96.34%	93.86M 72.89%
effect of forex changes on cash						-44K -
net change in cash	-4.56M -	91.49M 2,106.32%	227.13M 148.27%	-1.01M 100.45%	19.95M 2,067.26%	-155.31M 878.59%
cash at beginning of period	7.65M -	3.09M 59.61%	94.58M 2,960.78%	321.71M 240.16%	320.70M 0.32%	340.40M 6.14%
cash at end of period	3.09M -	94.58M 2,960.78%	321.71M 240.16%	320.70M 0.32%	340.65M 6.22%	185.08M 45.67%
operating cash flow	-9.65M -	2.49M 125.79%	-37.12M 1,590.64%	-94.81M 155.44%	-136.27M 43.72%	-119.06M 12.63%
capital expenditure	-49K -	-235K 379.59%	-1.09M 364.68%	-3.74M 242.49%	-2.82M 24.52%	-4.23M 49.77%
free cash flow	-9.70M -	2.25M 123.24%	-38.21M 1,794.41%	-98.55M 157.93%	-139.09M 41.13%	-123.29M 11.36%

All numbers in (except ratios and percentages)